SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Avid Bioservices Q4 EPS $(0.11) Beats $(0.16) Estimate, Sales $12.60M Beat $8.50M Estimate

Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.16) by 31.25 percent. This is a 450 percent decrease over losses of $(0.02) per share from

Benzinga · -
Avid Bioservices (NASDAQ: CDMO) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.16) by 31.25 percent. This is a 450 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $12.60 million which beat the analyst consensus estimate of $8.50 million by 48.24 percent. This is a 26.12 percent decrease over sales of $17.05 million the same period last year.